New data confirm Roche’s Vabysmo improves vision with fewer treatments for people with neovascular age-related macular degeneration Read more
FDA grants priority review to Roche’s Lunsumio for Relapsed or Refractory Follicular Lymphoma Read more
US FDA approves Roche’s Evrysdi for use in babies under two months with Spinal Muscular Atrophy Read more
European Commission approves Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma Read more
Roche reports interim results for phase-III Skycraper-01 study in PD-L1-high metastatic non-small cell lung cancer Read more
CHMP recommends EU conditional approval of Roche’s antibody Mosunetuzumab for people with relapsed Follicular Lymphoma Read more
New data for Roche’s Ocrevus show benefit in disability progression and cognitive decline in secondary progressive and primary progressive multiple sclerosis Read more